Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on weight and cardiovascular risk in abdominally obese subjects with impaired fasting glucose after rimonabant or placebo
2008-004497-40Phase 4Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in impaired fasting glucose (IFG), Abdominal adiposity (ABCD), diabetes mellitus (DM) and 1 more (2 arms), sponsored by Hull University Teaching Hospitals. Started Oct 2008; status: terminated.
02
Drugs
metformin
03
Conditions
impaired fasting glucose (IFG)Abdominal adiposity (ABCD)diabetes mellitus (DM)cardiac morbidity
Beyond the preview
Go deeper on 2008-004497-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004497-40.